1st Quarter - Report — PODESTA GROUP, INC. for GENZYME (2009)

Firm

PODESTA GROUP, INC.

Client

GENZYME

Income

$130,000

Expenses

—

What was lobbied

5 issue areas, each in the filer's own words, with who lobbied on it and where.

Budget/Appropriations BUD

H.R. 1 American Recovery and Reinvestment Act of 2009 S. Con. Res. 13 H. Con. Res. 85

Lobbyist	Covered position, as disclosed
SHARON COHEN	—
ANDREW KAUDERS	Sr. Adv. Sen. Menendez; ED, House Demo Caucus
ELIZABETH ANN MORRA	—
ANTHONY PODESTA	—
THOMAS B SPARKMAN	Health Policy Intern, Senate HELP Committee
NICOLE C YOUNG	—

Contacted: Food & Drug Administration (FDA); Health & Human Services, Dept of (HHS); SENATE; HOUSE OF REPRESENTATIVES

Bills named: S.Con.Res. 13 (111th), H.Con.Res. 85 (111th), H.R. 1 (111th)

Copyright/Patent/Trademark CPT

H.R. 574 Medicare Home Infusion Therapy Coverage Act of 2009 S. 254 Medicare Home Infusion Therapy Coverage Act of 2009

Lobbyist	Covered position, as disclosed
SHARON COHEN	—
COURTNEY HAGEN	—
ANTHONY PODESTA	—
THOMAS B SPARKMAN	Health Policy Intern, Senate HELP Committee
NICOLE C YOUNG	—

Contacted: Health & Human Services, Dept of (HHS); SENATE; Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES

Bills named: S. 254 (111th), H.R. 574 (111th)

Taxation/Internal Revenue Code TAX

Neglected Disease Tax Credit

Lobbyist	Covered position, as disclosed
PAUL BRATHWAITE	Exec. Dir., Congressional Black Caucus
SHARON COHEN	—
DAVID MARIN	Staff & Comm Dir.
THOMAS B SPARKMAN	Health Policy Intern, Senate HELP Committee
MICHELLE TESSIER	—
NICOLE C YOUNG	—

Contacted: Health & Human Services, Dept of (HHS); Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; SENATE

Medicare/Medicaid MMM

Medicare Issues S. 301 Physician Payments Sunshine Act of 2009

Lobbyist	Covered position, as disclosed
DANIELE BAIERLEIN	—
SHARON COHEN	—
RANDALL GERARD	—
ELIZABETH ANN MORRA	1995-2001 House Appropriations Committee
ANTHONY PODESTA	—
WALTER PRYOR	U.S. Senator David Pryor
THOMAS B SPARKMAN	Health Policy Intern, Senate HELP Committee
NICOLE C YOUNG	—

Contacted: Health & Human Services, Dept of (HHS); SENATE; HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA)

Bills named: S. 301 (111th)

Pharmacy PHA

H.R. 1427 Promoting Innovation and Access to Life-Saving Medicine Act H.R. 1548 Pathway for Biosimilars Act S. 726 Promoting Innovation and Access to Life-Saving Medicine Act Neglected Disease Issues

Lobbyist	Covered position, as disclosed
PAUL BRATHWAITE	Exec. Dir., Congressional Black Caucus
SHARON COHEN	—
ANTHONY PODESTA	—
THOMAS B SPARKMAN	Health Policy Intern, Senate HELP Committee
NICOLE C YOUNG	—

Contacted: SENATE; Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS)

Bills named: S. 726 (111th), H.R. 1427 (111th), H.R. 1548 (111th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.